Castle Biosciences, Inc. (CSTL)
33.50
-0.70
(-2.05%)
USD |
NASDAQ |
Aug 24, 16:00
33.50
0.00 (0.00%)
After-Hours: 20:00
Castle Biosciences Enterprise Value : 813.24M for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 813.24M |
| August 20, 2026 | 774.49M |
| August 19, 2026 | 755.88M |
| August 18, 2026 | 655.51M |
| August 17, 2026 | 683.57M |
| August 14, 2026 | 673.51M |
| August 13, 2026 | 701.88M |
| August 12, 2026 | 728.73M |
| August 11, 2026 | 753.44M |
| August 10, 2026 | 756.80M |
| August 07, 2026 | 747.03M |
| August 06, 2026 | 699.44M |
| August 05, 2026 | 697.30M |
| August 04, 2026 | 721.10M |
| August 03, 2026 | 697.00M |
| July 31, 2026 | 624.08M |
| July 30, 2026 | 587.17M |
| July 29, 2026 | 516.08M |
| July 28, 2026 | 498.69M |
| July 27, 2026 | 515.47M |
| July 24, 2026 | 522.95M |
| July 23, 2026 | 547.20M |
| July 22, 2026 | 526.76M |
| July 21, 2026 | 517.61M |
| July 20, 2026 | 498.85M |
| Date | Value |
|---|---|
| July 17, 2026 | 506.93M |
| July 16, 2026 | 509.07M |
| July 15, 2026 | 502.66M |
| July 14, 2026 | 475.20M |
| July 13, 2026 | 470.93M |
| July 10, 2026 | 493.51M |
| July 09, 2026 | 519.13M |
| July 08, 2026 | 491.07M |
| July 07, 2026 | 496.86M |
| July 06, 2026 | 508.46M |
| July 02, 2026 | 505.40M |
| July 01, 2026 | 523.71M |
| June 30, 2026 | 497.47M |
| June 29, 2026 | 511.84M |
| June 26, 2026 | 511.23M |
| June 25, 2026 | 469.12M |
| June 24, 2026 | 445.19M |
| June 23, 2026 | 422.77M |
| June 22, 2026 | 417.31M |
| June 18, 2026 | 414.89M |
| June 17, 2026 | 388.53M |
| June 16, 2026 | 394.90M |
| June 15, 2026 | 400.95M |
| June 12, 2026 | 402.17M |
| June 11, 2026 | 411.56M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| RadNet, Inc. | 7.797B |
| Lumexa Imaging Holdings, Inc. | 2.099B |
| Labcorp Holdings, Inc. | 33.85B |
| Quest Diagnostics, Inc. | 33.02B |
| OPKO Health, Inc. | 1.201B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.06M |
| Revenue (Quarterly) | 103.55M |
| Total Expenses (Quarterly) | 105.61M |
| EPS Diluted (Quarterly) | -0.0678 |
| Gross Profit Margin (Quarterly) | 74.29% |
| Profit Margin (Quarterly) | -1.99% |
| Earnings Yield | -1.94% |
| Normalized Earnings Yield | -2.129 |